Kilitch Drugs India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Kilitch Drugs India Ltd · Outcome · 07 Nov 2026, 2:19 am
Kilitch Drugs India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 5,022 (+2.6% YoY | +11.9% QoQ) ■ EBITDA: 668 (+32.6% YoY | +127.6% QoQ) ■ EBITDA Margin (%): 13.3 (+300 bps YoY | +677 bps QoQ) ■ PAT: 223 (-72.8% YoY | -23.5% QoQ) ■ EPS (INR): 0.64 (-74.3% YoY | -22.9% QoQ)
Original exchange filing (PDF)
More announcements from Kilitch Drugs India Ltd
- We are submitting Scrutinizer''s Report for evoting of EGM · 16 Nov 2026
- Proceeding of EGM held today i.e. 16th November, 2026 · 16 Nov 2026
- Intimation under regulation 30 of the SEBI LODR regulations 2015, corrigendum to the Notice of Extra Ordinary General Meeting · 13 Nov 2026
- We are submitting herewith the rectification of typo error in the outcome of Board meeting dated 22nd October, 2026 · 13 Nov 2026
- We are submitting herewith the outcome of the Board meeting · 07 Nov 2026
- Submitting unaudited financials results for quarter ended 30.09.2026 · 07 Nov 2026
- KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 06 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 06 Nov 2026
